EMEA (Europe, Middle East and Africa) Meningioma Drug Market Report 2018




In this report, the EMEA Meningioma Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Meningioma Drug for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. EMEA Meningioma Drug market competition by top manufacturers/players, with Meningioma Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including Arno Therapeutics Inc AstraZeneca Plc Boehringer Ingelheim GmbH Eli Lilly and Co Genentech Inc GlaxoSmithKline Plc Merck & Co Inc Merck KGaA Novartis AG Ono Pharmaceutical Co Ltd Pharma Mar SA Progenics Pharmaceuticals Inc On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into Abemaciclib Afatinib Dimaleate AR-42 Avelumab Others On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including Hospital Clinic Others If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

EMEA (Europe, Middle East and Africa) Meningioma Drug Market Report 2017
1 Meningioma Drug Overview
    1.1 Product Overview and Scope of Meningioma Drug
    1.2 Classification of Meningioma Drug
        1.2.1 EMEA Meningioma Drug Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Meningioma Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Abemaciclib
        1.2.4 Afatinib Dimaleate
        1.2.5 AR-42
        1.2.6 Avelumab
        1.2.7 Others
    1.3 EMEA Meningioma Drug Market by Application/End Users
        1.3.1 EMEA Meningioma Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 EMEA Meningioma Drug Market by Region
        1.4.1 EMEA Meningioma Drug Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Meningioma Drug (2012-2022)
        1.5.1 EMEA Meningioma Drug Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Meningioma Drug Revenue and Growth Rate (2012-2022)

2 EMEA Meningioma Drug Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Meningioma Drug Market Competition by Players/Manufacturers
        2.1.1 EMEA Meningioma Drug Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Meningioma Drug Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Meningioma Drug Sale Price by Players (2012-2017)
    2.2 EMEA Meningioma Drug (Volume and Value) by Type/Product Category
        2.2.1 EMEA Meningioma Drug Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Meningioma Drug Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Meningioma Drug Sale Price by Type (2012-2017)
    2.3 EMEA Meningioma Drug (Volume) by Application
    2.4 EMEA Meningioma Drug (Volume and Value) by Region
        2.4.1 EMEA Meningioma Drug Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Meningioma Drug Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Meningioma Drug Sales Price by Region (2012-2017)

3 Europe Meningioma Drug (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Meningioma Drug Sales and Value (2012-2017)
        3.1.1 Europe Meningioma Drug Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Meningioma Drug Revenue and Growth Rate (2012-2017)
    3.2 Europe Meningioma Drug Sales and Market Share by Type
    3.3 Europe Meningioma Drug Sales and Market Share by Application
    3.4 Europe Meningioma Drug Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Meningioma Drug Sales Volume by Countries (2012-2017)
        3.4.2 Europe Meningioma Drug Revenue by Countries (2012-2017)
        3.4.3 Germany Meningioma Drug Sales and Growth Rate (2012-2017)
        3.4.4 France Meningioma Drug Sales and Growth Rate (2012-2017)
        3.4.5 UK Meningioma Drug Sales and Growth Rate (2012-2017)
        3.4.6 Russia Meningioma Drug Sales and Growth Rate (2012-2017)
        3.4.7 Italy Meningioma Drug Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Meningioma Drug Sales and Growth Rate (2012-2017)

4 Middle East Meningioma Drug (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Meningioma Drug Sales and Value (2012-2017)
        4.1.1 Middle East Meningioma Drug Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Meningioma Drug Revenue and Growth Rate (2012-2017)
    4.2 Middle East Meningioma Drug Sales and Market Share by Type
    4.3 Middle East Meningioma Drug Sales and Market Share by Application
    4.4 Middle East Meningioma Drug Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Meningioma Drug Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Meningioma Drug Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Meningioma Drug Sales and Growth Rate (2012-2017)
        4.4.4 Israel Meningioma Drug Sales and Growth Rate (2012-2017)
        4.4.5 UAE Meningioma Drug Sales and Growth Rate (2012-2017)
        4.4.6 Iran Meningioma Drug Sales and Growth Rate (2012-2017)

5 Africa Meningioma Drug (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Meningioma Drug Sales and Value (2012-2017)
        5.1.1 Africa Meningioma Drug Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Meningioma Drug Revenue and Growth Rate (2012-2017)
    5.2 Africa Meningioma Drug Sales and Market Share by Type
    5.3 Africa Meningioma Drug Sales and Market Share by Application
    5.4 Africa Meningioma Drug Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Meningioma Drug Sales Volume by Countries (2012-2017)
        5.4.2 Africa Meningioma Drug Revenue by Countries (2012-2017)
        5.4.3 South Africa Meningioma Drug Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Meningioma Drug Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Meningioma Drug Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Meningioma Drug Sales and Growth Rate (2012-2017)

6 EMEA Meningioma Drug Manufacturers/Players Profiles and Sales Data
    6.1 Arno Therapeutics Inc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Meningioma Drug Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Arno Therapeutics Inc Meningioma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 AstraZeneca Plc
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Meningioma Drug Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 AstraZeneca Plc Meningioma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Boehringer Ingelheim GmbH
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Meningioma Drug Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Boehringer Ingelheim GmbH Meningioma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Eli Lilly and Co
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Meningioma Drug Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Eli Lilly and Co Meningioma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Genentech Inc
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Meningioma Drug Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Genentech Inc Meningioma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 GlaxoSmithKline Plc
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Meningioma Drug Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 GlaxoSmithKline Plc Meningioma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Merck & Co Inc
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Meningioma Drug Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Merck & Co Inc Meningioma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Merck KGaA
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Meningioma Drug Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Merck KGaA Meningioma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Novartis AG
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Meningioma Drug Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Novartis AG Meningioma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Ono Pharmaceutical Co Ltd
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Meningioma Drug Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Ono Pharmaceutical Co Ltd Meningioma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Pharma Mar SA
    6.12 Progenics Pharmaceuticals Inc

7 Meningioma Drug Manufacturing Cost Analysis
    7.1 Meningioma Drug Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Meningioma Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Meningioma Drug Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Meningioma Drug Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Meningioma Drug Market Forecast (2017-2022)
    11.1 EMEA Meningioma Drug Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Meningioma Drug Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Meningioma Drug Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Meningioma Drug Price and Trend Forecast (2017-2022)
    11.2 EMEA Meningioma Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Meningioma Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Meningioma Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Meningioma Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Meningioma Drug Sales Forecast by Type (2017-2022)
    11.7 EMEA Meningioma Drug Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer



List of Tables and Figures

    Figure Product Picture of Meningioma Drug
    Figure EMEA Meningioma Drug Sales Volume (K Pcs) by Type (2012-2022)
    Figure EMEA Meningioma Drug Sales Volume Market Share by Type (Product Category) in 2016
    Figure Abemaciclib Product Picture
    Figure Afatinib Dimaleate Product Picture
    Figure AR-42 Product Picture
    Figure Avelumab Product Picture
    Figure Others Product Picture
    Figure EMEA Meningioma Drug Sales Volume (K Pcs) by Application (2012-2022)
    Figure EMEA Sales Market Share of Meningioma Drug by Application in 2016
    Figure Hospital Examples
    Table Key Downstream Customer in Hospital
    Figure Clinic Examples
    Table Key Downstream Customer in Clinic
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure EMEA Meningioma Drug Market Size (Million USD) by Region (2012-2022)
    Figure Europe Meningioma Drug Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Europe Meningioma Drug Revenue (Million USD) Status and Forecast by Countries
    Figure Middle East Meningioma Drug Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Middle East Meningioma Drug Revenue (Million USD) Status and Forecast by Countries
    Figure Africa Meningioma Drug Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Africa Meningioma Drug Revenue (Million USD) Status and Forecast by Countries
    Figure EMEA Meningioma Drug Sales Volume and Growth Rate (2012-2022)
    Figure EMEA Meningioma Drug Revenue (Million USD) and Growth Rate (2012-2022)
    Figure EMEA Meningioma Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
    Table EMEA Meningioma Drug Sales Volume (K Pcs) of Major Players (2012-2017)
    Table EMEA Meningioma Drug Sales Share by Players (2012-2017)
    Figure 2016 Meningioma Drug Sales Share by Players
    Figure 2017 Meningioma Drug Sales Share by Players
    Figure EMEA Meningioma Drug Market Major Players Product Revenue (Million USD) (2012-2017)
    Table EMEA Meningioma Drug Revenue (Million USD) by Players (2012-2017)
    Table EMEA Meningioma Drug Revenue Share by Players (2012-2017)
    Table 2016 EMEA Meningioma Drug Revenue Share by Players
    Table 2017 EMEA Meningioma Drug Revenue Share by Players
    Table EMEA Meningioma Drug Sale Price (USD/Pcs) by Players (2012-2017)
    Table EMEA Meningioma Drug Sales (K Pcs) and Market Share by Type (2012-2017)
    Table EMEA Meningioma Drug Sales Share by Type (2012-2017)
    Figure Sales Market Share of Meningioma Drug by Type (2012-2017)
    Figure EMEA Meningioma Drug Sales Market Share by Type (2012-2017)
    Table EMEA Meningioma Drug Revenue (Million USD) and Market Share by Type (2012-2017)
    Table EMEA Meningioma Drug Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Meningioma Drug by Type in 2016
    Table EMEA Meningioma Drug Sale Price (USD/Pcs) by Type (2012-2017)
    Table EMEA Meningioma Drug Sales (K Pcs) and Market Share by Application (2012-2017)
    Table EMEA Meningioma Drug Sales Share by Application (2012-2017)
    Figure Sales Market Share of Meningioma Drug by Application (2012-2017)
    Figure EMEA Meningioma Drug Sales Market Share by Application in 2016
    Table EMEA Meningioma Drug Sales (K Pcs) and Market Share by Region (2012-2017)
    Table EMEA Meningioma Drug Sales Share by Region (2012-2017)
    Figure Sales Market Share of Meningioma Drug by Region (2012-2017)
    Figure EMEA Meningioma Drug Sales Market Share in 2016
    Table EMEA Meningioma Drug Revenue (Million USD) and Market Share by Region (2012-2017)
    Table EMEA Meningioma Drug Revenue Share by Region (2012-2017)
    Figure Revenue Market Share of Meningioma Drug by Region (2012-2017)
    Figure EMEA Meningioma Drug Revenue Market Share Regions in 2016
    Table EMEA Meningioma Drug Sales Price (USD/Pcs) by Region (2012-2017)
    Figure Europe Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Europe Meningioma Drug Revenue and Growth Rate (2012-2017)
    Table Europe Meningioma Drug Sales (K Pcs) by Type (2012-2017)
    Table Europe Meningioma Drug Market Share by Type (2012-2017)
    Figure Europe Meningioma Drug Market Share by Type in 2016
    Table Europe Meningioma Drug Sales (K Pcs) by Application (2012-2017)
    Table Europe Meningioma Drug Market Share by Application (2012-2017)
    Figure Europe Meningioma Drug Market Share by Application in 2016
    Table Europe Meningioma Drug Sales (K Pcs) by Countries (2012-2017)
    Table Europe Meningioma Drug Sales Market Share by Countries (2012-2017)
    Figure Europe Meningioma Drug Sales Market Share by Countries (2012-2017)
    Figure Europe Meningioma Drug Sales Market Share by Countries in 2016
    Table Europe Meningioma Drug Revenue (Million USD) by Countries (2012-2017)
    Table Europe Meningioma Drug Revenue Market Share by Countries (2012-2017)
    Figure Europe Meningioma Drug Revenue Market Share by Countries (2012-2017)
    Figure Europe Meningioma Drug Revenue Market Share by Countries in 2016
    Figure Germany Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure France Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure UK Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Russia Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Italy Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Benelux Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Middle East Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Middle East Meningioma Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Table Middle East Meningioma Drug Sales (K Pcs) by Type (2012-2017)
    Table Middle East Meningioma Drug Market Share by Type (2012-2017)
    Figure Middle East Meningioma Drug Market Share by Type (2012-2017)
    Table Middle East Meningioma Drug Sales (K Pcs) by Applications (2012-2017)
    Table Middle East Meningioma Drug Market Share by Applications (2012-2017)
    Figure Middle East Meningioma Drug Sales Market Share by Application in 2016
    Table Middle East Meningioma Drug Sales Volume (K Pcs) by Countries (2012-2017)
    Table Middle East Meningioma Drug Sales Volume Market Share by Countries (2012-2017)
    Figure Middle East Meningioma Drug Sales Volume Market Share by Countries in 2016
    Table Middle East Meningioma Drug Revenue (Million USD) by Countries (2012-2017)
    Table Middle East Meningioma Drug Revenue Market Share by Countries (2012-2017)
    Figure Middle East Meningioma Drug Revenue Market Share by Countries (2012-2017)
    Figure Middle East Meningioma Drug Revenue Market Share by Countries in 2016
    Figure Saudi Arabia Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Israel Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure UAE Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Iran Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Africa Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Africa Meningioma Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Table Africa Meningioma Drug Sales (K Pcs) by Type (2012-2017)
    Table Africa Meningioma Drug Sales Market Share by Type (2012-2017)
    Figure Africa Meningioma Drug Sales Market Share by Type (2012-2017)
    Figure Africa Meningioma Drug Sales Market Share by Type in 2016
    Table Africa Meningioma Drug Sales (K Pcs) by Application (2012-2017)
    Table Africa Meningioma Drug Sales Market Share by Application (2012-2017)
    Figure Africa Meningioma Drug Sales Market Share by Application (2012-2017)
    Table Africa Meningioma Drug Sales Volume (K Pcs) by Countries (2012-2017)
    Table Africa Meningioma Drug Sales Market Share by Countries (2012-2017)
    Figure Africa Meningioma Drug Sales Market Share by Countries (2012-2017)
    Figure Africa Meningioma Drug Sales Market Share by Countries in 2016
    Table Africa Meningioma Drug Revenue (Million USD) by Countries (2012-2017)
    Table Africa Meningioma Drug Revenue Market Share by Countries (2012-2017)
    Figure Africa Meningioma Drug Revenue Market Share by Countries (2012-2017)
    Figure Africa Meningioma Drug Revenue Market Share by Countries in 2016
    Figure South Africa Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Nigeria Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Egypt Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Algeria Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Arno Therapeutics Inc Meningioma Drug Basic Information List
    Table Arno Therapeutics Inc Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Arno Therapeutics Inc Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Arno Therapeutics Inc Meningioma Drug Sales Market Share in EMEA (2012-2017)
    Figure Arno Therapeutics Inc Meningioma Drug Revenue Market Share in EMEA (2012-2017)
    Table AstraZeneca Plc Meningioma Drug Basic Information List
    Table AstraZeneca Plc Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure AstraZeneca Plc Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure AstraZeneca Plc Meningioma Drug Sales Market Share in EMEA (2012-2017)
    Figure AstraZeneca Plc Meningioma Drug Revenue Market Share in EMEA (2012-2017)
    Table Boehringer Ingelheim GmbH Meningioma Drug Basic Information List
    Table Boehringer Ingelheim GmbH Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Boehringer Ingelheim GmbH Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Boehringer Ingelheim GmbH Meningioma Drug Sales Market Share in EMEA (2012-2017)
    Figure Boehringer Ingelheim GmbH Meningioma Drug Revenue Market Share in EMEA (2012-2017)
    Table Eli Lilly and Co Meningioma Drug Basic Information List
    Table Eli Lilly and Co Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Eli Lilly and Co Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Eli Lilly and Co Meningioma Drug Sales Market Share in EMEA (2012-2017)
    Figure Eli Lilly and Co Meningioma Drug Revenue Market Share in EMEA (2012-2017)
    Table Genentech Inc Meningioma Drug Basic Information List
    Table Genentech Inc Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Genentech Inc Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Genentech Inc Meningioma Drug Sales Market Share in EMEA (2012-2017)
    Figure Genentech Inc Meningioma Drug Revenue Market Share in EMEA (2012-2017)
    Table GlaxoSmithKline Plc Meningioma Drug Basic Information List
    Table GlaxoSmithKline Plc Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure GlaxoSmithKline Plc Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure GlaxoSmithKline Plc Meningioma Drug Sales Market Share in EMEA (2012-2017)
    Figure GlaxoSmithKline Plc Meningioma Drug Revenue Market Share in EMEA (2012-2017)
    Table Merck & Co Inc Meningioma Drug Basic Information List
    Table Merck & Co Inc Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Merck & Co Inc Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Merck & Co Inc Meningioma Drug Sales Market Share in EMEA (2012-2017)
    Figure Merck & Co Inc Meningioma Drug Revenue Market Share in EMEA (2012-2017)
    Table Merck KGaA Meningioma Drug Basic Information List
    Table Merck KGaA Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Merck KGaA Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Merck KGaA Meningioma Drug Sales Market Share in EMEA (2012-2017)
    Figure Merck KGaA Meningioma Drug Revenue Market Share in EMEA (2012-2017)
    Table Novartis AG Meningioma Drug Basic Information List
    Table Novartis AG Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Novartis AG Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Novartis AG Meningioma Drug Sales Market Share in EMEA (2012-2017)
    Figure Novartis AG Meningioma Drug Revenue Market Share in EMEA (2012-2017)
    Table Ono Pharmaceutical Co Ltd Meningioma Drug Basic Information List
    Table Ono Pharmaceutical Co Ltd Meningioma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Ono Pharmaceutical Co Ltd Meningioma Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Ono Pharmaceutical Co Ltd Meningioma Drug Sales Market Share in EMEA (2012-2017)
    Figure Ono Pharmaceutical Co Ltd Meningioma Drug Revenue Market Share in EMEA (2012-2017)
    Table Pharma Mar SA Meningioma Drug Basic Information List
    Table Progenics Pharmaceuticals Inc Meningioma Drug Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Meningioma Drug
    Figure Manufacturing Process Analysis of Meningioma Drug
    Figure Meningioma Drug Industrial Chain Analysis
    Table Raw Materials Sources of Meningioma Drug Major Manufacturers in 2016
    Table Major Buyers of Meningioma Drug
    Table Distributors/Traders List
    Figure EMEA Meningioma Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure EMEA Meningioma Drug Revenue and Growth Rate Forecast (2017-2022)
    Figure EMEA Meningioma Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
    Table EMEA Meningioma Drug Sales (K Pcs) Forecast by Region (2017-2022)
    Figure EMEA Meningioma Drug Sales Market Share Forecast by Region (2017-2022)
    Table EMEA Meningioma Drug Revenue (Million USD) Forecast by Region (2017-2022)
    Figure EMEA Meningioma Drug Revenue Market Share Forecast by Region (2017-2022)
    Table Europe Meningioma Drug Sales (K Pcs) Forecast by Countries (2017-2022)
    Figure Europe Meningioma Drug Sales Market Share Forecast by Countries (2017-2022)
    Table Europe Meningioma Drug Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Europe Meningioma Drug Revenue Market Share Forecast by Countries (2017-2022)
    Table Middle East Meningioma Drug Sales (K Pcs) Forecast by Countries (2017-2022)
    Figure Middle East Meningioma Drug Sales Market Share Forecast by Countries (2017-2022)
    Table Middle East Meningioma Drug Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Middle East Meningioma Drug Revenue Market Share Forecast by Countries (2017-2022)
    Table Africa Meningioma Drug Sales (K Pcs) Forecast by Countries (2017-2022)
    Figure Africa Meningioma Drug Sales Market Share Forecast by Countries (2017-2022)
    Table Africa Meningioma Drug Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Africa Meningioma Drug Revenue Market Share Forecast by Countries (2017-2022)
    Table EMEA Meningioma Drug Sales (K Pcs) Forecast by Type (2017-2022)
    Figure EMEA Meningioma Drug Sales Market Share Forecast by Type (2017-2022)
    Table EMEA Meningioma Drug Sales (K Pcs) Forecast by Application (2017-2022)
    Figure EMEA Meningioma Drug Sales Market Share Forecast by Application (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Let our analyst help you with a customized solution for your market research needs

Select the license

Credit card Logo
hkjkhjkhjkhjkmjhjhkhjkjkhjkhjkm
Discount  Check Discount Question  Any Questions
hkjkhjkhjkhjkmjhjhkhjkjkhjkhjkm
fgfhfhfgf